We serve 5-O-Trityl-2,3,-anhydrothymidine CAS:25442-42-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-O-Trityl-2,3,-anhydrothymidine
CAS.NO:25442-42-6
Synonyms:
5-O-Triphenylmethyl-2-deoxy-2,3-didehyrothymidine
Molecular Formula: C29H26N2O4
Molecular Weight: 466.52800
Physical and Chemical Properties:
Density: 1.27 g/cm3
Boiling point: 595.7ºC at 760 mmHg
Melting point: /
Flash point:314.1ºC
Refractive index: 1.651
Specification:
Appearance: White crystalline powder
Purity:≥99%
Impurity: less than 0.3%
Moisture Content: less than 0.3%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Zidovudine CAS:30516-87-1
Contact us for information like 5-O-Trityl-2,3,-anhydrothymidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-O-Triphenylmethyl-2-deoxy-2,3-didehyrothymidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-O-Trityl-2,3,-anhydrothymidine Use and application,5-O-Trityl-2,3,-anhydrothymidine technical grade,usp/ep/jp grade.
Related News: The novel coronavirus has resulted in thousands of confirmed human infections in more than 20 countries, with more than 99 percent of cases in China.2-Amino-3-Bromo-6-Methylpyridine manufacturer As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.4-Pentyloxyphenylboronic acid supplier As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.4-(Trifluoromethoxy)benzyl chloride vendor The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data.This requires enterprises to have high R & D strength and strategic foresight, keep reserves projects, and seize the market after patents expire.
